Nu Skin Enterprises (NUS) Could Be Losing China License - Citron; Could Be Bad for USANA (USNA)
Tweet
Share
E-mailGet Alerts NUS Hot Sheet
Price: $12.70 --0%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 9.2%
EPS Growth %: -51.4%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 9.2%
EPS Growth %: -51.4%
Join SI Premium – FREE
Nu Skin Enterprises Inc. (NYSE: NUS) sees some weakness as Citron Research said there is a rumor that the company is losing its license in China.
If this is true, it would also be bad for USANA Health Sciences Inc. (NASDAQ: USNA).
If this is true, it would also be bad for USANA Health Sciences Inc. (NASDAQ: USNA).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- European stocks 'priced for macro perfection' - BofA
- US stocks saw largest 2-week outflow since December 2022 - BofA
- Wall Street's "fear gauge" at over 5-month high on rate cut, Mideast worries
Create E-mail Alert Related Categories
Trader TalkRelated Entities
Citron ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
